CODY BEER: Open Payments
NPI 1396208310 · PEKIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 31 payments from 17 companies in 2025. Trend: 2023 $247 · 2024 $378 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $117 |
| Novo Nordisk Inc | 3 | $110 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| ABBVIE INC. | 3 | $69 |
| Amgen Inc. | 3 | $58 |
| Astellas Pharma US Inc | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $49 |
| Lilly USA, LLC | 2 | $33 |
| SCPHARMACEUTICALS INC. | 1 | $31 |
Products named: INTELLIS ADAPTIVESTIM, Ozempic, Veozah, REXULTI, Cologuard Collection Kit, LEQVIO, UBRELVY, EVENITY.
Industry payments across IL — which companies pay providers there.
